Pages that link to "Q42200242"
Jump to navigation
Jump to search
The following pages link to Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV. (Q42200242):
Displaying 50 items.
- Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children (Q26782280) (← links)
- Pneumococcal serotype evolution in Western Europe (Q26782963) (← links)
- Using Pneumococcal Carriage Data to Monitor Postvaccination Changes in the Incidence of Pneumococcal Otitis Media (Q31136900) (← links)
- Pneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world (Q31157042) (← links)
- Reduction in all-cause otitis media-related outpatient visits in children after PCV10 introduction in Brazil (Q33778646) (← links)
- Aboriginal and non-Aboriginal children in Western Australia carry different serotypes of pneumococci with different antimicrobial susceptibility profiles (Q33801670) (← links)
- Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trial (Q33848675) (← links)
- Cost-effectiveness analysis of the available pneumococcal conjugated vaccines for children under five years in Colombia (Q35425552) (← links)
- Trends in antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae isolated from nasopharyngeal flora in children with acute otitis media in France before and after 13 valent pneumococcal conjugate vaccine introduction (Q35669561) (← links)
- Do Pneumococcal Conjugate Vaccines Represent Good Value for Money in a Lower-Middle Income Country? A Cost-Utility Analysis in the Philippines (Q35679740) (← links)
- Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel (Q35796784) (← links)
- Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine. (Q35813537) (← links)
- A longitudinal study of streptococcus pneumoniae carriage in healthy children in the 13-valent pneumococcal conjugate vaccine era (Q35887787) (← links)
- Epidemiology of Otitis Media with Spontaneous Perforation of the Tympanic Membrane in Young Children and Association with Bacterial Nasopharyngeal Carriage, Recurrences and Pneumococcal Vaccination in Catalonia, Spain - The Prospective HERMES Study (Q36266462) (← links)
- Panel 1: Epidemiology and Diagnosis (Q36333077) (← links)
- Management of acute otitis media in children six months of age and older (Q36592918) (← links)
- Surveillance of pneumococcal diseases in Central and Eastern Europe (Q37197020) (← links)
- Streptococcus pneumoniae serotype 19A: Worldwide epidemiology (Q38637072) (← links)
- Overall effectiveness of pneumococcal conjugate vaccines: an economic analysis of PHiD-CV and PCV-13 in the immunization of infants in Italy (Q38682554) (← links)
- The future of paediatric pneumococcal conjugate vaccines (Q38737534) (← links)
- Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex disease (Q38795739) (← links)
- Developing a vaccine to prevent otitis media caused by nontypeable Haemophilus influenzae (Q38905937) (← links)
- Prevalence and risk factors for Staphylococcus aureus nasopharyngeal carriage during a PCV trial (Q38913523) (← links)
- Direct and indirect effects of the 13-valent pneumococcal conjugate vaccine administered to infants and young children (Q38956348) (← links)
- Pneumococcal conjugate vaccines for preventing otitis media. (Q39502163) (← links)
- Influence of the pneumococcal conjugate vaccines on the temporal variation of pneumococcal carriage and the nasal microbiota in healthy infants: a longitudinal analysis of a case-control study (Q40122112) (← links)
- Impact of pneumococcal conjugate vaccines for children in high- and non-high-income countries (Q40242598) (← links)
- Pneumococcal carriage and serotype variation before and after introduction of pneumococcal conjugate vaccines in patients with acute otitis media in Switzerland (Q40299174) (← links)
- Impact of Widespread Introduction of Pneumococcal Conjugate Vaccines on Pneumococcal and Nonpneumococcal Otitis Media (Q40659753) (← links)
- The impact of pneumococcal conjugate vaccines on carriage of and disease caused by Streptococcus pneumoniae serotypes 6C and 6D in southern Israel (Q40699965) (← links)
- Challenges in the management of acute mastoiditis in children (Q41027900) (← links)
- A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation (Q41053483) (← links)
- Multicenter surveillance of Streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era. (Q41485091) (← links)
- Severity of pneumococcal versus non-pneumococcal acute otitis media in children (Q41491650) (← links)
- Economic burden of pneumococcal infections in children under 5 years of age. (Q41997001) (← links)
- La prise en charge de l’otite moyenne aiguë chez les enfants de six mois et plus (Q46913156) (← links)
- Otitis Media in Fully Vaccinated Preschool Children in the Pneumococcal Conjugate Vaccine Era. (Q47135375) (← links)
- Pneumococcal vaccination and chronic respiratory diseases (Q47162758) (← links)
- Cost-effectiveness analysis of routine 13-valent pneumococcal conjugate vaccinations in Chinese infants (Q48504304) (← links)
- Antimicrobial susceptibility and fluctuations in clonal complexes of serogroup 6 Streptococcus pneumoniae isolates collected from children in Beijing, China, between 1997 and 2016. (Q52335136) (← links)
- Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection. (Q52371735) (← links)
- Effects of Pneumococcal Conjugate Vaccine on Genotypic Penicillin Resistance and Serotype Changes, Japan, 2010-2017 (Q58550643) (← links)
- Acute otitis media, antimicrobial prescriptions, and medical expenses among children in the United States during 2011-2016 (Q58569850) (← links)
- Panel 6: Vaccines (Q59651656) (← links)
- Changes in the serotype distribution of Streptococcus pneumoniae causing otitis media after PCV13 introduction in Spain (Q60301335) (← links)
- Prescription of Antibacterial Drugs for HIV-Exposed, Uninfected Infants, Malawi, 2004-2010 (Q60922609) (← links)
- Antibiotic Recommendations for Acute Otitis Media and Acute Bacterial Sinusitis: Conundrum No More (Q88146853) (← links)
- Otitis media (Q88290056) (← links)
- Prevalence of middle ear abnormalities from otitis media in relation with pneumococcal vaccine use in the Inuit population of Nunavik, province of Quebec, Canada (Q90347421) (← links)
- The impact of PCV7/13 on the distribution of carried pneumococcal serotypes and on pilus prevalence; 14 years of repeated cross-sectional surveillance (Q90730842) (← links)